Boston Property Plant And Equipment Gross vs Cash And Short Term Investments Analysis

BSX Stock  USD 77.35  1.23  1.62%   
Boston Scientific financial indicator trend analysis is way more than just evaluating Boston Scientific Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Boston Scientific Corp is a good investment. Please check the relationship between Boston Scientific Property Plant And Equipment Gross and its Cash And Short Term Investments accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Property Plant And Equipment Gross vs Cash And Short Term Investments

Property Plant And Equipment Gross vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Boston Scientific Corp Property Plant And Equipment Gross account and Cash And Short Term Investments. At this time, the significance of the direction appears to have very week relationship.
The correlation between Boston Scientific's Property Plant And Equipment Gross and Cash And Short Term Investments is 0.29. Overlapping area represents the amount of variation of Property Plant And Equipment Gross that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Boston Scientific Corp, assuming nothing else is changed. The correlation between historical values of Boston Scientific's Property Plant And Equipment Gross and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant And Equipment Gross of Boston Scientific Corp are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Property Plant And Equipment Gross i.e., Boston Scientific's Property Plant And Equipment Gross and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.29
Relationship DirectionPositive 
Relationship StrengthVery Weak

Property Plant And Equipment Gross

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Boston Scientific Corp balance sheet. This account contains Boston Scientific investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Boston Scientific Corp fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Most indicators from Boston Scientific's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Boston Scientific Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
At this time, Boston Scientific's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 679.4 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.29 in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit8.1B8.7B9.9B10.4B
Total Revenue11.9B12.7B14.2B15.0B

Boston Scientific fundamental ratios Correlations

0.960.820.730.970.990.940.50.890.621.00.670.620.940.630.740.930.130.630.770.770.830.10.590.710.78
0.960.860.80.910.930.990.460.860.610.960.770.610.910.580.760.870.140.60.820.670.850.230.590.680.85
0.820.860.910.740.820.860.280.850.480.810.840.480.860.540.560.780.390.550.720.630.730.340.50.650.86
0.730.80.910.640.730.830.190.760.270.720.930.270.840.520.430.730.580.50.670.580.630.670.530.610.89
0.970.910.740.640.970.870.650.90.640.970.550.640.880.50.640.940.030.50.650.80.780.010.430.580.77
0.990.930.820.730.970.910.50.930.580.980.660.580.950.590.670.970.110.580.710.840.790.080.530.690.78
0.940.990.860.830.870.910.410.830.460.940.820.470.930.590.730.870.190.60.820.670.790.320.640.680.84
0.50.460.280.190.650.50.410.590.450.50.040.450.3-0.290.050.55-0.41-0.230.050.560.3-0.13-0.31-0.180.57
0.890.860.850.760.90.930.830.590.550.890.650.560.890.380.490.940.080.410.580.810.70.120.30.530.85
0.620.610.480.270.640.580.460.450.550.590.181.00.390.30.590.45-0.130.430.540.290.78-0.260.170.410.48
1.00.960.810.720.970.980.940.50.890.590.670.590.940.630.740.930.130.620.770.760.810.110.60.70.77
0.670.770.840.930.550.660.820.040.650.180.670.180.810.580.490.660.580.570.70.460.60.640.610.660.77
0.620.610.480.270.640.580.470.450.561.00.590.180.390.30.590.45-0.130.430.540.290.78-0.260.170.410.48
0.940.910.860.840.880.950.930.30.890.390.940.810.390.690.670.940.290.650.760.780.730.270.670.770.77
0.630.580.540.520.50.590.59-0.290.380.30.630.580.30.690.820.460.520.960.840.260.690.170.950.950.28
0.740.760.560.430.640.670.730.050.490.590.740.490.590.670.820.530.060.890.940.270.88-0.040.830.860.38
0.930.870.780.730.940.970.870.550.940.450.930.660.450.940.460.530.070.450.590.920.670.120.420.60.77
0.130.140.390.580.030.110.19-0.410.08-0.130.130.58-0.130.290.520.060.070.420.28-0.010.160.690.450.410.3
0.630.60.550.50.50.580.6-0.230.410.430.620.570.430.650.960.890.450.420.910.210.810.130.90.960.32
0.770.820.720.670.650.710.820.050.580.540.770.70.540.760.840.940.590.280.910.320.920.250.840.890.59
0.770.670.630.580.80.840.670.560.810.290.760.460.290.780.260.270.92-0.010.210.320.440.050.20.410.63
0.830.850.730.630.780.790.790.30.70.780.810.60.780.730.690.880.670.160.810.920.440.10.620.810.68
0.10.230.340.670.010.080.32-0.130.12-0.260.110.64-0.260.270.17-0.040.120.690.130.250.050.10.280.170.51
0.590.590.50.530.430.530.64-0.310.30.170.60.610.170.670.950.830.420.450.90.840.20.620.280.880.27
0.710.680.650.610.580.690.68-0.180.530.410.70.660.410.770.950.860.60.410.960.890.410.810.170.880.4
0.780.850.860.890.770.780.840.570.850.480.770.770.480.770.280.380.770.30.320.590.630.680.510.270.4
Click cells to compare fundamentals

Boston Scientific Account Relationship Matchups

Boston Scientific fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets30.6B30.8B32.2B32.5B35.1B36.9B
Short Long Term Debt Total10.3B9.5B9.5B9.3B9.5B10.0B
Other Current Liab2.8B3.0B3.0B2.7B3.2B3.4B
Total Current Liabilities4.9B3.7B4.3B3.8B4.9B5.2B
Total Stockholder Equity13.9B15.3B16.6B17.6B19.3B20.2B
Property Plant And Equipment Net2.4B2.5B2.7B2.8B3.3B3.5B
Net Debt10.1B7.8B7.5B8.4B8.6B9.1B
Retained Earnings(2.3B)(2.4B)(1.4B)(750M)819M860.0M
Accounts Payable542M513M794M862M942M989.1M
Non Current Assets Total25.9B24.1B25.9B26.7B28.6B30.1B
Non Currrent Assets Other735M545M563M707M679M713.0M
Net Receivables1.9B1.5B1.8B2.0B2.2B2.3B
Common Stock Shares Outstanding1.4B1.4B1.4B1.4B1.5B1.2B
Liabilities And Stockholders Equity30.6B30.8B32.2B32.5B34.9B36.6B
Non Current Liabilities Total11.8B11.8B11.3B11.1B10.7B6.2B
Inventory1.6B1.4B1.6B1.9B2.5B2.6B
Other Current Assets324M410M385M350M333M426.3M
Other Stockholder Equity15.8B17.5B17.7B18.0B18.4B10.0B
Total Liab16.7B15.5B15.6B14.9B15.6B8.6B
Property Plant And Equipment Gross2.4B2.5B2.3B2.4B6.8B7.1B
Total Current Assets4.7B6.7B6.3B5.8B6.5B3.3B
Accumulated Other Comprehensive Income270M207M263M269M49M51.5M
Short Term Debt1.4B13M261M20M531M417.5M
Intangible Assets7.9B5.9B6.1B5.9B6.0B4.9B
Other Liab3.0B2.2B2.1B1.8B2.1B1.9B
Other Assets(2M)4.6B3M2M(1M)950K
Long Term Debt8.6B9.1B8.8B8.9B8.6B5.6B
Good Will10.2B10.0B12.0B12.9B14.4B8.6B
Property Plant Equipment2.1B2.1B2.3B2.8B3.3B1.7B
Current Deferred Revenue144M138M208M220M266M333.1M
Net Tangible Assets(4.2B)9.4B(1.7B)11.7B13.4B14.1B
Retained Earnings Total Equity(2.3B)(2.4B)(1.4B)(750M)(862.5M)(905.6M)
Long Term Debt Total8.6B9.1B8.8B8.9B10.3B6.6B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Boston Stock Analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.